Pembrolizumab and EV With Radiation Therapy for MIBC Patients (PEVRAD)

NCT05879653 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: MK-3475
DRUG: ASG-22CE
PROCEDURE: maximal TURBT
RADIATION: Radiation therapy

Sponsor

Kyoto University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]